Neonatal jaundice primary prevention

Jump to navigation Jump to search

Neonatal jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neonatal jaundice from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neonatal jaundice primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neonatal jaundice primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neonatal jaundice primary prevention

on Neonatal jaundice primary prevention

Neonatal jaundice primary prevention in the news

Blogs on Neonatal jaundice primary prevention

Directions to Hospitals Treating Neonatal jaundice

Risk calculators and risk factors for Neonatal jaundice primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

Effective measures for the primary prevention of neonatal jaundice include breastfeeding of the infants and avoidance of dextrose water supplementation of the breastfed infants.

Primary Prevention

  • Effective measures recommended by the American Academy of Pediatrics (AAP) for the primary prevention of neonatal jaundice include the following:[1]
    • Breastfeeding of the infants 8-12 times per day, inadequate breastfeeding leads to jaundice development
    • Avoidance of dextrose water supplementation of the breasfed infants

References

  1. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004). "Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation". Pediatrics. 114 (1): 297–316. PMID 15231951.

​​ Template:WH Template:WS